Synergistic effects of dendritic cell targeting and laser-microporation on enhancing epicutaneous skin vaccination efficacy.

Machado, Y, Duinkerken, S, Hoepflinger, V, Mayr, M, Korotchenko, E, Kurtaj, A, Pablos, I, Steiner, M, Stoecklinger, A, Lübbers, J, Schmid, M, Ritter, U, Scheiblhofer, S, Ablinger, M, Wally, V, Hochmann, S, Raninger, AM, Strunk, D, van Kooyk, Y, Thalhamer, J, Weiss, R. J Control Release. 2017, 266:87-99.

The first meeting of the Austrian Expert Panel for Molecular Cancer Profiling.

Seeber, A, Gastl, G, Eisterer, W, Gampenrieder, SP, Gerger, A, Kieler, M, Pichler, M, Prager, GW, Untergasser, G, Weltermann, A, Greil, R. MEMO-MAG EUR MED ONC. 2017, 10(4): 255-258.

Clinical Outcomes of 217 Patients with Acute Erythroleukemia According to Treatment Type and Line: A Retrospective Multinational Study

Almeida, AM, Prebet, T, Itzykson, R, Ramos, F, Al-Ali, H, Shammo, J, Pinto, R, Maurillo, L, Wetzel, J, Musto, P, Van De Loosdrecht, AA, Costa, MJ, Esteves, S, Burgstaller, S, Stauder, R, Autzinger, EM, Lang, A, Krippl, P, Geissler, D, Falantes, JF, Pedro, C, Bargay, J, Deben, G, Garrido, A, Bonanad, S, Diez-Campelo, M, Thepot, S, Ades, L, Sperr, WR, Valent, P, Fenaux, P, Sekeres, MA, Greil, R, Pleyer, L. INT J MOL SCI. 2017, 18(4): 837.

When the guardian sleeps: Reactivation of the p53 pathway in cancer.

Merkel, O, Taylor, N, Prutsch, N, Staber, PB, Moriggl, R, Turner, SD, Kenner, L. Mutat Res. 2017, 773:1-13.

Distribution and Metabolism of Lipocurc™ (Liposomal Curcumin) in Dog and Human Blood Cells: Species Selectivity and Pharmacokinetic Relevance.

Bolger, GT, Licollari, A, Tan, AM, Greil, R, Vcelar, B, Majeed, M, Helson, L. ANTICANCER RES. 2017, 37(7): 3483-3492.

Endothelin-1 genetic polymorphism as predictive marker for bevacizumab in metastatic breast cancer.

Gampenrieder, SP, Hufnagl, C, Brechelmacher, S, Huemer, F, Hackl, H, Rinnerthaler, G, Romeder, F, Monzo Fuentes, C, Morre, P, Hauser-Kronberger, C, Mlineritsch, B, Greil, R. Pharmacogenomics J. 2017, 17(4):344-350.

COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis Bullosa.

Hainzl, S, Peking, P, Kocher, T, Murauer, EM, Larcher, F, Del Rio, M, Duarte, B, Steiner, M, Klausegger, A, Bauer, JW, Reichelt, J, Koller, U. Mol Ther. 2017.

Red blood cell alloimmunization in 184 patients with myeloid neoplasms treated with azacitidine – A retrospective single center experience.

Leisch, M, Weiss, L, Lindlbauer, N, Jungbauer, C, Egle, A, Rohde, E, Greil, R, Grabmer, C, Pleyer, L. Leuk Res. 2017, 59:12-19.

Prognostic score in patients with recurrent or metastatic carcinoma of the head and neck treated with cetuximab and chemotherapy.

Magnes, T, Melchardt, T, Weiss, L, Mittermair, C, Neureiter, D, Klieser, E, Gampenrieder, S, Moser, G, Gaggl, A, Greil, R, Egle, A. PLoS One. 2017, 12(7):e0180995.

Update on squamous cell carcinoma of the head and neck: ASCO annual meeting 2017.

Magnes, T, Egle, A, Greil, R, Melchardt, T. Memo. 2017, 10(4):220-223.